Helene F. S. Negaard

Author

Also Known As

H F S Negaard, H. Negaard, H.F.S. NEGAARD, H.F.S. Negaard, Helene F. Negaard, Helene F. S. Negaard, Helene F.S. Negaard, Helene FS Negaard, Helene Negaard

Publications

809

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital St Olav's University Hospital Norwegian University of Science and Technology University Hospital of North Norway University of Oslo

About

Helene F. S. Negaard is an author at Oslo University Hospital specializing in medicine, pathology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	204
2	Pathology	3	3	129
3	Immunology	2	2	47
4	Health Sciences	1	1	82
5	Cell Biology	1	1	14

Helene F. S. Negaard

Publications

745

Citations

H-Index

Page 1

	Year	Citations
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium Silke Gillessen, Nicolas Sauvé, Laurence Collette, Journal of Clinical Oncology	2021	220
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium J. Beyer, Laurence Collette, Nicolas Sauvé, Journal of Clinical Oncology	2021	160
Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors Helene F. S. Negaard, Nina Iversen, Inger Marie Bowitz-Lothe, Leukemia ThrombosisAngiogenesisMicrovascular DysfunctionHematologyHaematological Malignancies	2008	82
Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era Ragnhild Hellesnes, Øivind Kvammen, Tor Åge Myklebust, International Journal of Cancer	2019	63
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group Axel Gerdtsson, Ulf Håkansson, Magnus Törnblom, European Urology Oncology UrologySurgical OncologyPopulation-based StudyGynecological SurgerySurgery	2019	53
Hypercoagulability in patients with haematological neoplasia: No apparent initiation by tissue factor Per Ole Iversen, Bjørn Østenstad, Nina Iversen, Thrombosis and Haemostasis	2008	41
Increased acquired activated protein C resistance in unselected patients with hematological malignancies Helene F. S. Negaard, Per Ole Iversen, Bjørn Østenstad, Journal of Thrombosis and Haemostasis Hematological MalignancyUnselected PatientsOncogenic AgentMedicineMalignant Blood Disorder	2008	33
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study Hege Sagstuen Haugnes, Helene F. S. Negaard, Hilde Jensvoll, European Urology Open Science	2021	24
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group Axel Gerdtsson, Anna Thor, Anna Grenabo Bergdahl, European Urology Oncology UrologySurgical OncologyPopulation-based Mapping StudyNonseminoma PatientsMedicine	2021	22
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study Ragnhild Hellesnes, Tor Åge Myklebust, Roy M. Bremnes, Journal of Clinical Oncology	2020	18

Page 1